The Global Immunoassay Industry is positioned for a remarkable expansion, driven by its critical role in medical diagnostics. According to a recent analysis, the market is expected to register a solid Compound Annual Growth Rate (CAGR) of 5% from 2022 to 2032. This translates to a projected market valuation of US$45.78 billion by 2032, signifying …